US0303711081 - Common Stock

Taking everything into account, **AVD** scores **4** out of 10 in our fundamental rating. **AVD** was compared to 84 industry peers in the **Chemicals** industry. **AVD** scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. **AVD** is not valued too expensively and it also shows a decent growth rate.

Of the past 5 years **AVD** 4 years had a positive operating cash flow.

Looking at the **Return On Assets**, with a value of **0.91%**, **AVD** is in line with its industry, outperforming **40.48%** of the companies in the same industry.

With a **Return On Invested Capital** value of **3.60%**, **AVD** perfoms like the industry average, outperforming **48.81%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **AVD** is in line with the industry average of **6.70%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.91% | ||

ROE | 1.92% | ||

ROIC | 3.6% |

ROA(3y)2.48%

ROA(5y)2.34%

ROE(3y)4.81%

ROE(5y)4.52%

ROIC(3y)4.94%

ROIC(5y)4.23%

In the last couple of years the **Profit Margin** of **AVD** has declined.

Looking at the **Operating Margin**, with a value of **4.80%**, **AVD** is doing worse than **64.29%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **AVD** has declined.

In the last couple of years the **Gross Margin** of **AVD** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 4.8% | ||

PM (TTM) | 1.21% | ||

GM | 31.05% |

OM growth 3Y1.8%

OM growth 5Y-13.38%

PM growth 3Y-26.84%

PM growth 5Y-24.6%

GM growth 3Y-6.33%

GM growth 5Y-5.11%

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so **AVD** is destroying value.

Compared to 5 years ago, **AVD** has less shares outstanding

An Altman-Z score of **2.21** indicates that **AVD** is not a great score, but indicates only limited risk for bankruptcy at the moment.

A Debt/Equity ratio of **0.50** indicates that **AVD** is somewhat dependend on debt financing.

Looking at the **Debt to Equity ratio**, with a value of **0.50**, **AVD** is in the better half of the industry, outperforming **60.71%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.5 | ||

Debt/FCF | N/A | ||

Altman-Z | 2.21 |

ROIC/WACC0.4

WACC9.05%

A Current Ratio of **2.29** indicates that **AVD** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.29 | ||

Quick Ratio | 1.12 |

Looking at the last year, **AVD** shows a small growth in **Revenue**. The Revenue has grown by **0.72%** in the last year.

EPS 1Y (TTM)-62.35%

EPS 3Y-11.88%

EPS 5Y-20.52%

EPS Q2Q%-14.29%

Revenue 1Y (TTM)0.72%

Revenue growth 3Y8.1%

Revenue growth 5Y4.98%

Sales Q2Q%8.21%

Based on estimates for the next years, **AVD** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **90.58%** on average per year.

EPS Next Y127.25%

EPS Next 2Y90.58%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year6.6%

Revenue Next 2Y6.8%

Revenue Next 3YN/A

Revenue Next 5YN/A

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Based on the **Price/Earnings** ratio of **35.16**, the valuation of **AVD** can be described as expensive.

The rest of the industry has a similar **Price/Earnings** ratio as **AVD**.

With a **Price/Forward Earnings** ratio of **9.31**, the valuation of **AVD** can be described as very reasonable.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **20.22**, **AVD** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 35.16 | ||

Fwd PE | 9.31 |

Compared to the rest of the industry, the **Enterprise Value to EBITDA** ratio of **AVD** indicates a somewhat cheap valuation: **AVD** is cheaper than 79.76% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 8.3 |

The low **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)0.28

PEG (5Y)N/A

EPS Next 2Y90.58%

EPS Next 3YN/A

The stock price of **AVD** dropped by **-30.35%** in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.

With a **Dividend Yield** of **1.39**, **AVD** pays less dividend than the S&P500 average, which is at **2.38**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.39% |

On average, the dividend of **AVD** grows each year by **9.54%**, which is quite nice.

Dividend Growth(5Y)9.54%

Div Incr Years3

Div Non Decr Years3

The dividend of **AVD** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP47.23%

EPS Next 2Y90.58%

EPS Next 3YN/A

**AMERICAN VANGUARD CORP**

NYSE:AVD (6/21/2024, 7:04:00 PM)

After market: 8.7916 +0 (+0.02%)**8.79**

**+0.16 (+1.85%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap245.94M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.39% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 35.16 | ||

Fwd PE | 9.31 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)0.28

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.91% | ||

ROE | 1.92% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 4.8% | ||

PM (TTM) | 1.21% | ||

GM | 31.05% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.75

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.5 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.29 | ||

Quick Ratio | 1.12 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-62.35%

EPS 3Y-11.88%

EPS 5Y

EPS Q2Q%

EPS Next Y127.25%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)0.72%

Revenue growth 3Y8.1%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y